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Abstract 1 
Background: The underlying etiology of colorectal cancer (CRC) includes both 2 
genetic variation and environmental exposures. The main aim of this study was to 3 
search for interaction effects between well-established environmental CRC risk factors 4 
and published common genetic variants exerting main effects on CRC risk. 5 
Methods: We used a two-phase approach: (i) Discovery phase (2,652 incident CRC 6 
cases and 10,608 controls from UK Biobank) and (ii) Validation phase (1,656 cases and 7 
2,497 controls from the Study of Colorectal Cancer in Scotland). Interactions with 8 
nominal P<0.05 in phase I were taken forward for validation in phase II. Furthermore, 9 
we constructed a weighted genetic risk score (GRS) of CRC risk for each individual 10 
and studied interactions between the GRS and all the environmental risk factors.   11 
Results: Seventy of the 1,500 tested interactions were found to be nominally significant 12 
in phase I. After testing these 70 interactions in phase II, the interaction between 13 
rs11903757 (2q32.3/NABP1) and body mass index (BMI) was nominally significant 14 
(P=0.02) with the same direction of effects. After performing fixed-effect meta-15 
analyses to combine the results from both phases, the rs11903757*BMI interaction was 16 
also found to be statistically significant (OR=1.26; 95% CI, 1.10-1.44; 17 
Pinteraction=6.03×10-4; Pheterogeneity=0.63). No interactions involving the GRS were 18 
statistically significant in either of the two datasets. 19 
Conclusions: Limited evidence of gene-environment interactions in CRC risk was 20 
observed. There are potential modifications of the rs11903757 effect by BMI on CRC 21 
risk. 22 
Impact: Our findings might contribute to identifying subpopulations with different 23 
susceptibility to the effect of BMI on CRC risk. 24 
4 
 
Introduction  1 
Worldwide, colorectal cancer (CRC) is the third most common cancer by incidence and 2 
second by mortality, with over 1.8 million new cases and 881,000 deaths in 2018 (1). 3 
The underlying etiology of CRC includes both genetic variation and environmental 4 
exposures (2). It has been suggested that the interplay between genetic variants and 5 
environmental risk factors, known as gene-environment (G×E) interaction, may also 6 
contribute to “missing heritability” of CRC risk (3). Thus, identification of G×E in CRC 7 
risk should help to explain the undiscovered heritability of CRC, provide insights into 8 
CRC etiology, and identify subpopulations with high CRC risk and potential to benefit 9 
most from early intervention for CRC.  10 
To date, few studies have explored G×E interactions on CRC risk (2, 4), partly because 11 
assembling comprehensive datasets with both risk factor exposures and genotyping data 12 
is a major challenge. We recently evaluated the evidence across the meta-analyses of 13 
candidate gene studies and genome-wide G×E interaction analyses that investigated 14 
G×E interactions in CRC (2). Notably, moderate strength of evidence was found for 15 
some G×E interactions between several single-nucleotide polymorphisms (SNPs) and 16 
alcohol drinking, processed meat intake, estrogen plus progestogen therapy use and 17 
nonsteroidal anti-inflammatory drug (NSAID) use (2). 18 
Two recently published genome-wide association studies (GWAS) (5, 6) have identified 19 
several new genetic variants associated with CRC risk. However, the role of G×E 20 
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interactions involving these GWAS-identified common genetic variants underlying 1 
CRC susceptibility remains largely unknown. In this study, we searched for interaction 2 
effects between 100 GWAS-identified independent genetic variants (linkage 3 
disequilibrium r2 < 0.2) exerting main effects on CRC risk and well-established 4 
environmental CRC risk factors, including standing height, body mass index (BMI), 5 
smoking (status and pack-years of smoking), NSAID (aspirin and others) use, hormonal 6 
replacement therapy (HRT) use, physical activity, alcohol use, and dietary intakes of 7 
processed meat, red meat, vegetables, fruit, fiber and calcium. These environmental risk 8 
factors were selected based on the results of meta-analyses and systematic reviews from 9 
the World Cancer Research Fund International/American Institute for Cancer Research 10 
Third Expert Report (7) and the subsequent Continuous Update Project Report (8). In 11 
particular, it has been reported that diet low in calcium (20.5%), alcohol use (15.2%), 12 
smoking (13.3%), BMI (8.6%) and diet low in fiber (11.6%) were the risk factors that 13 
contributed most to disability-adjusted life-year estimates of CRC at the global level in 14 
2017 (9).  15 
Here, we utilize a two-phase approach to test for the interactions between common 16 
genetic risk factors associated with CRC at genome-wide levels of significance and 17 
environmental risk factors supported by sufficient evidence for association with CRC 18 
risk from the reports (7, 8), including: (i) Discovery phase using UK Biobank data and 19 
(ii) Validation phase using study samples from the Study of Colorectal Cancer in 20 
Scotland (SOCCS). Furthermore, we constructed a weighted genetic risk score (GRS) 21 
of CRC risk for each individual by incorporating information of the 100 independent 22 
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genetic variants and studied interactions between the GRS and all the environmental 1 
risk factors.  2 
Materials and methods 3 
Study population 4 
We used individual-level data from the UK Biobank cohort and SOCCS in our analysis 5 
(Table 1). 6 
Case-control study from the UK Biobank cohort 7 
The UK Biobank is a large cohort study that has recruited more than half a million 8 
people aged 40 to 69 years throughout the UK between 2006 and 2010. Questionnaire 9 
data, physical measurements, blood and urine samples were collected at the baseline 10 
assessment of UK Biobank (10). The web-based 24-hour dietary assessment was 11 
applied to collect information on the intakes of foods and beverages consumed during 12 
the 24-hour period before the assessment (11). Data abstracted from the UK Biobank 13 
study consisted of 4,800 incident and prevalent CRC cases and 20,289 population-14 
based controls after the process of genotyping quality control (6). Of all the CRC cases, 15 
2,652 (55.3%) were incident and 2,119 (44.1%) were prevalent cases. However, 1,907 16 
(90.0%) prevalent CRC cases were diagnosed more than one year before recruitment, 17 
which can be a source of bias. Therefore, we only included a total of 2,652 incident 18 
CRC cases and 10,608 controls in the discovery phase of the study (Table 1). 19 
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Research ethics approval for UK Biobank to collect participant data was obtained from 1 
the National Information Governance Board for Health and Social Care and the North 2 
West Multicentre Research Ethics Committee. Genotypic and phenotypic data used in 3 
this study were obtained from UK Biobank under an approved data request application 4 
(application ID: 7441). 5 
Study of Colorectal Cancer in Scotland (SOCCS) 6 
SOCCS is a large population-based case-control study of CRC. Details of SOCCS have 7 
been described previously (12). Briefly, SOCCS has recruited cases of adenocarcinoma 8 
of colorectum who were aged 16-79 years in Scotland (12). Population-based controls 9 
who were identified through the Community Health Index were randomly invited to 10 
participate in SOCCS (12). In this study, we included a total of 1,656 CRC cases and 11 
2,497 controls who had available phenotype and genetic data (Table 1).   12 
SOCCS received research ethics approval from the MultiCentre Research Ethics 13 
Committee for Scotland and relevant Local Research Ethics committees (12). All 14 
participants provided written informed consent (12).  15 
Genotyping and quality control 16 
A total of 100 GWAS-identified independent genetic variants (linkage disequilibrium 17 
r2 < 0.2) were examined, those identified in two recently published GWAS studies (5, 18 
6). For the SNPs that were located at the same locus and in linkage disequilibrium, we 19 
selected the ones that were described in Law PJ, et al. (6). For the UK Biobank genotype 20 
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data, biological samples of the participants were genotyped using two closely related 1 
arrays from Affymetrix: the custom-designed Affymetrix UK BiLEVE Axiom array on 2 
an initial 50,000 participants and Affymetrix UK Biobank Axiom array on the 3 
remaining 450,000 participants. The procedure of genotyping and quality control was 4 
previously reported (13). Details of phasing and imputation were previously described 5 
by Bycroft et al., 2018 (13). In brief, prediction of un-genotyped variants was done 6 
using IMPUTE4 software with a combination of reference panels including: (i) the 7 
Haplotype Reference Consortium panel; and (ii) the merged UK10K and 1000 Genome 8 
phase 3 reference panel.  9 
For SOCCS, samples were genotyped using Illumina HumanHap300, HumanHap240S 10 
arrays (14) and OmniExpressExome BeadChip 8v1.1, 8v1.250 or 8v1.3 (Illumina Inc., 11 
San Diego, CA) (15). Un-genotyped variants were imputed using SHAPEIT v2.837 and 12 
IMPUTE v2.3.2. We used two reference panels for imputation: the 1000 Genome 13 
reference panel, phase 1, December 2013 release and the UK10K reference panel 14 
(release April 2014). For the X chromosome, genotypes were phased and imputed as 15 
for the autosomal chromosome, with the inclusion of the “chrX” flag. X chromosome 16 
variants were coded as 0 and 2 for men, assuming complete inactivation of one allele 17 
in females and equal effect-size between males and females. Details of imputation and 18 
subsequent quality control of imputed genotypes are given elsewhere (6). 19 
Phenotype data 20 
Cancer cases of UK Biobank were identified through data linkage to national cancer 21 
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and death registries and Hospital Episode Statistics. CRC cases in UK Biobank were 1 
defined using two different revisions of the International Classification of Diseases 2 
(ICD), ICD-10 or ICD-9 (6). Height (standing and sitting) and weight were measured 3 
during the baseline physical measurement of UK Biobank (10). Information on lifestyle 4 
factors and food intakes was gathered using a self-reported touchscreen questionnaire 5 
at recruitment. Information on daily intakes of nutrients was collected using a web-6 
based 24-hour dietary assessment tool about four years after the baseline assessment. 7 
The 24-hour dietary assessments were performed in one-third of the UK Biobank 8 
participants and was available for 947 CRC cases and 4,160 controls in our dataset. The 9 
derivation of each environmental variable in the UK Biobank dataset is described in 10 
Supplementary Methods. The environmental data were harmonized between the UK 11 
Biobank dataset and the SOCCS dataset whenever possible.  12 
The CRC cases of SOCCS were defined based on histologically confirmed 13 
adenocarcinoma of the colon or rectum (codes 153 or 154 in ICD, 9th revision or ICD10 14 
C18, C19 or C20 codes) (15). SOCCS study participants that were recruited before 15 
2009 had completed two questionnaires: The Lifestyle and Cancer Questionnaire and 16 
The Scottish Collaborative Group Food Frequency Questionnaire (12). The derivation 17 
of each environmental variable in the SOCCS dataset has been described previously 18 
(12).  19 
Statistical methods 20 
The association between each genetic variant, each environmental risk factor and CRC 21 
10 
 
risk was examined by using logistic regression models. Within the UK Biobank dataset, 1 
models were adjusted for age (age of CRC diagnosis for cases and age at recruitment 2 
for controls), sex and assessment center, and analyses involving genetic variants were 3 
further adjusted for the first 10 genetic principal components. Within the SOCCS 4 
dataset, models were adjusted for age (age of CRC diagnosis for cases and age at 5 
recruitment for controls) and sex. In addition, models of the analysis of dietary nutrients 6 
were further adjusted for total energy intake.  7 
To test for the interactions, the two-phase approach was applied. Interactions with 8 
nominal P values < 0.05 in phase I were further tested in phase II. Case-control logistic 9 
regression analyses including G×E interaction term(s) were applied to test for the 10 
multiplicative interactions. Models were adjusted for age, sex, assessment center and 11 
the first 10 genetic principal components in phase I (the UK Biobank dataset), whereas 12 
models were adjusted for age and sex in phase II (the SOCCS dataset). In addition, 13 
models of the interaction analysis involving dietary nutrients were further adjusted for 14 
total energy intake. Furthermore, for interactions with nominal P values < 0.05 in phase 15 
II, we performed fixed-effect meta-analyses to combine phase I and phase II results, 16 
and obtained summary odds ratios (ORs) and 95% confidence intervals (CIs), with 17 
estimation of heterogeneity measured by Cochran Q test (I2) and its P value (16).   18 
False Discovery Rate (17) was used to account for multiple testing in phase II. P values 19 
unadjusted before multiple testing were termed nominal P values, whereas P values 20 
after adjustment for multiple testing were termed adjusted P values and were used to 21 
11 
 
evaluate the statistical significance of a given interaction at the 0.05 level. 1 
For interactions with nominal P values < 0.05 in phase II, we further examined (i) the 2 
main effect of the environmental risk factor stratified by the SNP, (ii) the main effect of 3 
the SNP stratified by the environmental risk factor and (iii) the combined association 4 
stratified by both the environmental risk factor and the SNP. Also, we used an extension 5 
of the Human Genome Epidemiology Network’s Venice criteria (3, 18) to evaluate the 6 
strength of the evidence for the G×E interactions with nominal P values < 0.05 in phase 7 
II. The detailed evaluation process has been described elsewhere (2, 3).   8 
To calculate the weighted GRS of CRC risk for each individual, a meta-analysis 9 
excluding the UK Biobank and SOCCS study samples was first performed in order to 10 
obtain unbiased regression coefficients (β-estimates) of CRC risk associated with the 11 
genetic variants. Directly genotyped SNPs were coded as 0, 1 or 2 copies of the variant 12 
allele. For imputed SNPs, we used the estimated number of copies of the count allele 13 
(the ‘dosage’) with values between 0-2. Both genotyped and imputed SNPs were treated 14 
as continuous variables (i.e. log-additive model). The weighted GRS was then 15 
calculated by summing up the dosages of effect alleles weighted by their effect 16 
estimates retrieved from the meta-analysis of GWAS and were Z-transformed to 17 
normalize the distributions. Models were adjusted for the same covariates as the 18 
examination of interactions between the individual SNPs and the environmental risk 19 
factors. 20 
Analyses were conducted using R 3.4.4 (https://www.R-project.org/). Power 21 
12 
 
calculations were performed using the Quanto software (19, 20). All statistical tests 1 
were two-sided. 2 
Results 3 
Study characteristics are presented in Table 1. Briefly, 2,652 incident CRC cases and 4 
10,608 controls from the UK Biobank cohort were included in phase I, whereas 1,656 5 
cases and 2,497 controls from SOCCS were included in phase II. The summary 6 
statistics of the environmental risk factors for these two datasets are presented in 7 
Supplementary Table S1. The associations between the environmental risk factors, the 8 
100 SNPs and CRC risk are presented in Supplementary Tables S2 and S3, separately. 9 
After testing 1,500 G×E in phase I, a total of 70 G×E interactions showed nominal P 10 
values < 0.05 (Supplementary Table S4). These interactions were further tested in 11 
phase II, in which two interactions showed nominal P values < 0.05, including the 12 
interactions between rs11903757 (2q32.3/NABP1) and BMI (nominal P = 0.02), and 13 
rs2735940 (5p15.33/TERT) and smoking status (nominal P = 0.04) (Table 2). In 14 
particular, the rs11903757*BMI interaction was found with the same direction of 15 
effects. However, neither of the two interactions reached statistical significance after 16 
accounting for multiple testing based on the 70 tests performed in phase II. After 17 
performing fixed-effect meta-analyses for these two interactions, statistical significance 18 
was observed for the interaction between rs11903757 and per 10 kg/m2 increase in BMI 19 
(OR = 1.26; 95% CI, 1.10-1.44; Pinteraction = 6.03×10-4; Pheterogeneity = 0.63) (Table 2). 20 
Furthermore, the rs11903757*BMI interaction was observed with statistical 21 
13 
 
significance in men after performing meta-analyses in stratified subgroups according 1 
to sex (OR = 1.32; 95% CI, 1.08-1.60; Pinteraction = 5.53×10-3; Pheterogeneity = 0.78) (Table 2 
2).  3 
Stratification analyses were performed for the rs11903757*BMI interaction and the 4 
rs2735940*smoking status interaction in the UK Biobank dataset and the SOCCS 5 
dataset, respectively (Supplementary Tables S5 to S8). For the rs11903757*BMI 6 
interaction, above median BMI significantly increased CRC risk in individuals with TC 7 
genotype (OR = 1.27; 95% CI, 1.07-1.50; P = 5.69×10-3) and non-significantly in 8 
individuals with CC genotype (OR = 1.32; 95% CI, 0.70-2.52; P = 0.393) but not in 9 
those with TT genotype (P = 0.352) in the UK Biobank dataset when stratified by 10 
genotypes of rs11903757 (Supplementary Table S5). Also, the effect of BMI on CRC 11 
risk stratified by genotypes of rs11903757 was limited to men in the UK Biobank 12 
dataset (Supplementary Table S5). For the rs2735940*smoking status interaction, 13 
ever smokers (compared to non-smokers) significantly increased CRC risk in 14 
individuals with AA genotype (OR = 1.32; 95% CI, 1.10-1.57; P = 2.77×10-3) but not 15 
in those with AG genotype (P = 0.060) or GG genotype (P = 0.972) in the UK Biobank 16 
dataset when stratified by genotypes of rs2735940 (Supplementary Table S7).  17 
Table 3 presents the evaluation of evidence for the rs11903757*BMI interaction and 18 
the rs2735940*smoking status interaction by using an extension of the Venice criteria 19 
(3, 18). The environmental effects of BMI on CRC risk was graded as class III 20 
(suggestive) (2) (Supplementary Table S9). The main effect of rs11903757 21 
14 
 
(2q32.3/NABP1) on CRC risk was graded as strong (AAA, based on the Venice criteria 1 
(18, 21)) in a meta-analysis of 12,696 cases and 15,113 controls of European descent 2 
(OR = 1.16; 95% CI, 1.10-1.22; P = 3.71×10-8; Pheterogeneity = 0.27) (Supplementary 3 
Table S10). Consequently, the interaction between rs11903757 (2q32.3/NABP1) and 4 
BMI was given a moderate prior score (Moderate-2) and a weak overall credibility 5 
score (Table 3). No evidence was found for the interaction between rs2735940 6 
(5p15.33/TERT) and smoking (Table 3).  7 
Table 4 presents the interaction effects between the weighted GRS and the 8 
environmental risk factors on CRC risk in the UK Biobank dataset and the SOCCS 9 
dataset. The distributions of the weighted GRS among the participants in the two 10 
datasets are shown in Supplementary Figure 1 (A) and (B), respectively. The OR of 11 
the GRS was 1.64 (95% CI, 1.57-1.72; P < 2×10-16) in the UK Biobank dataset and 1.64 12 
(95% CI, 1.52-1.78; P < 2×10-16) in the SOCCS dataset, separately. No interactions 13 
involving the GRS were statistically significant in either of the two datasets (Table 4).   14 
The power to detect a G×E interaction was estimated for the phase I data at a 0.05 15 
significance level, assuming a main effect of 1.10 for log-additive SNPs 16 
(Supplementary Figures S2 to S4). We only calculated the power for binary 17 
environmental variables because statistical power would be higher for continuous 18 
exposure variables (10). The prevalence of binary environmental exposures and the 19 
environmental ORs were chosen according to the dataset used in phase I 20 
(Supplementary Tables S1 and S2). With a sample size of 2,652 cases and 10,608 21 
15 
 
controls in the whole dataset, we had sufficient power (80%) to detect moderate (OR > 1 
1.30) and strong (OR > 2.00) G×E interaction effects if the SNP was at least moderately 2 
polymorphic [minor allele frequency (MAF) = 0.20]. Similarly, the analysis of HRT use 3 
was restricted to women (1,098 cases and 4,608 controls) and the analysis of dietary 4 
nutrients was limited to the participants who had taken part in the web-based 24-hour 5 
dietary assessment of UK Biobank (947 cases and 4,160 controls in our study), we 6 
therefore had sufficient power (80%) to detect strong (OR > 2.00) G×E interaction 7 
effects for a moderately polymorphic (MAF = 0.20).  8 
Discussion 9 
Using a two-phase approach, followed by a fixed-effect meta-analysis, we searched for 10 
G×E interaction effects between 100 published common genetic variants and 15 11 
environmental variables. Two of the 70 G×E interactions with nominal significance in 12 
phase I showed nominal P values < 0.05 in phase II, including the interactions between 13 
rs11903757 (2q32.3/NABP1) and BMI (P = 0.02), and rs2735940 (5p15.33/TERT) and 14 
smoking status (P = 0.04). In particular, the rs11903757*BMI interaction was found 15 
with the same direction of effects and showed statistical significance in the meta-16 
analysis. No statistically significant interactions were found between the weighted GRS 17 
for CRC and the environmental risk factors in either of the two datasets.  18 
The interaction between rs11903757 (2q32.3/NABP1) and BMI was nominally 19 
significant with the same direction of effects in our study. The individual effects of 20 
rs11903757 (2q32.3/NABP1) and BMI on CRC risk have been previously explored, but 21 
16 
 
the biological mechanisms behind this interaction remains unclear. Rs11903757 is an 1 
intergenic SNP at 2q32.3 with closest proximity to the gene nucleic acid binding 2 
protein 1 (NABP1) (44 kb centromeric) and the gene serum deprivation response 3 
(SDPR) (112 kb telomeric), which encodes the serum-deprivation response 4 
phosphatidylserine-binding protein (22). Also, rs11903757 is expression quantitative 5 
trait loci for NABP1 expression in whole blood (P = 2.1×10-15) and non-sun exposed 6 
skin (P = 3.2×10-6) based on the results from the Genotype-Tissue Expression (GTEx) 7 
project (23). Previously, the SNP rs11903757 was found to be associated with CRC risk 8 
in a GWAS of European and Asian case-control studies (OR = 1.15 per risk allele; P = 9 
3.7×10-8) (22). Additionally, no statistically significant associations were observed 10 
between this genotype and CRC survival in a population-based study of 5,675 patients 11 
after CRC diagnosis in Scotland (24). The NABP1 gene binds single-stranded DNA via 12 
the oligonucleotide/oligosaccharide binding fold domain (25). Single-stranded DNA 13 
binding proteins are essential for diverse DNA processes (22). Evidence from previous 14 
biologic data also suggests that NABP1 plays a critical role in genomic stability, which 15 
could explain the development of cancer (26). BMI was used as a proxy variable of 16 
body fatness in our analysis because it has been reported to be strongly correlated with 17 
percentage body fat according to results from laboratory methods (10). Greater body 18 
fatness, which can be measured by BMI, waist circumference and waist-to-hip ratio, 19 
has been reported as a risk factor for CRC (8).    20 
Hutter et al., 2012 (27) and Kantor et al., 2014 (28) performed two meta-analyses of 21 
G×E interactions between a total of 26 GWAS-identified CRC risk loci and a number 22 
17 
 
of environmental factors. Only the interaction between rs16892766 (8q23.3/EIF3H) 1 
and vegetable consumption showed statistically significance after accounting for 2 
multiple testing in the meta-analysis with a sample size of 7,016 CRC cases and 9,723 3 
controls (OR = 1.88; 95% CI, 1.36-2.59; nominal Pinteraction = 1.34×10-4; adjusted 4 
Pinteraction = 0.02; Pheterogeneity = 0.68) (27). However, this interaction was not replicated 5 
in phase I of our study (OR = 1.00; 95% CI, 0.85-1.17; P = 0.996). Additionally, the 6 
rs11903757*BMI (per 10 kg/m2) interaction was found with nominal statistical 7 
significance in phase II of our study and with statistical significance in the meta-8 
analysis, was not detected by Kantor, et al. (per 10 kg/m2 increase; OR = 1.07; 95% CI, 9 
0.94-1.22; Pinteraction = 0.28; Pheterogeneity = 0.45) (28). There may be multiple reasons 10 
behind these observations. One of the possible reasons is that Hutter et al. (27) and 11 
Kantor et al. (28) included both nested case-control studies and case-control studies in 12 
their meta-analysis, while we only used a prospective study (including 2,652 incident 13 
CRC cases and 10,608 controls) in phase I and therefore will be less affected by recall 14 
bias or reverse causality, when weight was already affected by the presence of cancer 15 
disease.   16 
The strengths of this study are that first, we examined for the first time the presence of 17 
potential effect-modifications for the SNPs newly identified from the two recently 18 
published meta-analyses of GWAS (5, 6). Second, we evaluated G×E interactions for a 19 
wide range of environmental CRC risk factors, for which valid information was 20 
collected across the studies. For the dataset used in phase I, we only used incident CRC 21 
cases and controls from the UK Biobank cohort. Therefore, the information on lifestyle 22 
18 
 
factors and dietary habits was collected before cancer diagnosis, which minimized 1 
recall bias and differential misclassifications. Though SOCCS is a case-control study, 2 
participants were asked to provide information about general lifestyle and the 3 
consumption of each food item one year prior to diagnosis for cases and one year prior 4 
to recruitment for controls (12). Third, we critically evaluated the cumulative evidence 5 
for the identified interactions using predetermined guidelines (3, 18), which have been 6 
used to assess the cumulative evidence of G×E interaction effects on cancer risk (2, 4, 7 
29). Lastly, for the first time we examined the interaction effects between the weighted 8 
GRS for CRC and a wide variety of environmental CRC risk factors. One study has 9 
examined joint effects between GRSs and plasma 25-hydroxyvitamin D (25(OH)D) on 10 
CRC risk (30). However, no evidence for the modification of genetic susceptibility for 11 
CRC according to vitamin D status was observed (30). 12 
However, there are several limitations. First, our study had limited power to detect weak 13 
(OR < 1.30) or moderate (1.30 < OR < 2.00) interactions for SNPs with MAF less than 14 
0.20 even if we used the whole dataset in phase I. Furthermore, the analysis of HRT use 15 
was restricted to women [hence has a reduced sample size and power] and information 16 
on dietary nutrient intakes in the UK Biobank cohort was collected from the web-based 17 
24-hour dietary recall assessments [found in only one-third of all UK Biobank 18 
participant which again restricted sample size and power]. Therefore, further studies 19 
with larger sample sizes are needed to examine the interaction effects. Second, we used 20 
a prospective cohort study in phase I and a case-control study in phase II. Both types of 21 
these studies have different sources of error. For case-control studies, recall bias and 22 
19 
 
differential misclassifications can bias estimates and may lead to false negatives. For 1 
our study, cases may recall their exposure better than controls because information on 2 
general lifestyle and food intakes was collected using self-reported questionnaires in 3 
SOCCS. Prospective studies can minimize differential misclassification because the 4 
information of lifestyle factors and dietary habits was collected for all participants at 5 
recruitment. However, they may have variable time period between baseline data 6 
collection and cancer diagnosis (28). In addition, we attempted to harmonize the 7 
environmental variables in the UK Biobank cohort and the SOCCS, though the two 8 
studies used different methods for data collection. Despite these concerns, the 9 
associations between the environmental risk factors and CRC risk in the prospective 10 
dataset of UK Biobank were consistent with previous observations (7, 8). Third, there 11 
is a “healthy volunteer” selection bias in UK Biobank, which means that the participants 12 
of UK Biobank are probably more aware of health issues than non-participants (31). 13 
Therefore, the UK Biobank cohort is not fully representative of the UK general 14 
population (31).   15 
Conclusion 16 
In conclusion, using a two-phase approach, we were able to observe a statistically 17 
significant G×E interaction between rs11903757 (2q32.3/NABP1) and BMI in CRC 18 
risk. Functional studies and further replications are needed to confirm our findings and 19 
uncover the mechanisms of the interactions between BMI and genetic variants. Also, 20 
larger studies incorporating information from consortia are needed to fully examine the 21 
20 
 
impact of genetic variation on the effect of BMI on CRC risk, thus to provide insights 1 
into CRC etiology, and identity subpopulations who will benefit most from early 2 
intervention for CRC. 3 
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